Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Virology|March 17, 2021
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization AssaysJingyou Yu, Zhenfeng Li, Xuan He, et al.
Journal of Virology|November 15, 2024
Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaquesJoseph P Nkolola, David Hope, Ruoran Guan, et al.
Plos Pathogens|April 22, 2022
HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeysBrian Moldt, Abishek Chandrashekar, Erica N Borducchi, et al.
NPJ Vaccines|January 31, 2026
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infectionShlomi Ilan, Yannic Bartsch, Wonyeong Jung, et al.
Journal of Virology|January 8, 2010
Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigsJoseph P Nkolola, Hanqin Peng, Ethan C Settembre, et al.
Journal of Virology|June 27, 2014
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimerJoseph P Nkolola, Christine A Bricault, Ann Cheung, et al.
Science Translational Medicine|July 20, 2022
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaquesJoseph P Nkolola, Jingyou Yu, Huahua Wan, et al.
Science (New York, N.Y.)|September 7, 2019
Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaquesPeter Abbink, Noe B Mercado, Joseph P Nkolola, et al.
Journal of Virology|December 26, 2014
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual componentChristine A Bricault, James M Kovacs, Joseph P Nkolola, et al.
Pageof 5